TrialJournal for immunotherapy of cancer2021

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma.

Yosuke Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.